Discover
SGP
SpyGlass Pharma, Inc.
24.92
2 x 18.11
1 x 25.13
bid
ask
+
0.30
1.22%
2 @ 04:00 PM
24.92 +0.00 (0.00%)
| Ytd | -5.61% | |
| 1y | -5.61% |
24.63
day range
25.65
17.56
52 week range
29.68
| Open | 25.03 | Prev Close | 24.62 | Low | 24.63 | High | 25.65 | Mkt Cap | 833.52M |
| Vol | 68.25K | Avg Vol | 110.00K | EPS | -2.51 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 26.38 | 200-d Avg | 24.07 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 21.97M | ||
| Research and Development Expense | 10.94M | ||
| Selling, General and Administrative Expense | 11.03M | ||
| Operating Income | -21.97M | ||
| Net Income | -19.86M | ||
| Net Income Common Stock | -19.86M | ||
| Net Income Common Stock (USD) | -19.86M | ||
| Consolidated Income | -19.86M | ||
| Earnings per Basic Share | -0.59 | ||
| Earnings per Basic Share (USD) | -0.59 | ||
| Earnings per Diluted Share | -0.59 | ||
| Earning Before Interest & Taxes (EBIT) | -19.86M | ||
| Earning Before Interest & Taxes (USD) | -19.86M | ||
| Weighted Average Shares | 33.44M | ||
| Weighted Average Shares Diluted | 33.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 223.14M | ||
| Cash and Equivalents (USD) | 223.14M | ||
| Investments | 11.04M | ||
| Investments Current | 11.04M | ||
| Trade and Non-Trade Receivables | 678.00K | ||
| Current Assets | 236.46M | ||
| Property, Plant & Equipment Net | 6.21M | ||
| Total Assets | 243.43M | ||
| Total Debt | 1.63M | ||
| Current Liabilities | 9.44M | ||
| Debt Non-Current | 1.63M | ||
| Total Liabilities | 11.07M | ||
| Accumulated Retained Earnings (Deficit) | -138.41M | ||
| Shareholders Equity | 232.36M | ||
| Shareholders Equity (USD) | 232.36M | ||
| Assets Non-Current | 6.97M | ||
| Total Debt (USD) | 1.63M | ||
| Liabilities Non-Current | 1.63M | ||
| Trade and Non-Trade Payables | 4.16M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 404.00K | ||
| Net Cash Flow from Financing | 13.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -15.76M | ||
| Capital Expenditure | -1.93M | ||
| Issuance (Purchase) of Equity Shares | 31.00K | ||
| Net Cash Flow from Investing | -933.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 999.00K | ||
| Net Cash Flow from Operations | -14.84M | ||
| Share Based Compensation | 2.09M | ||